Abstract
A major aim in immunology has been to understand how the immune system evokes characteristic responses to infection, foreign tissue grafts and tumours. The current view of immunoregulation is based mainly on studies of lymphocyte subsets, either in vitro1–3 or by adoptive transfer to irradiated recipients4. Many reagents are available for defining T-cell subsets5–8, but only recently have there been helper T-cell-specific antibodies9,10 against the mouse equivalent of the Leu3/T4 (man) and W3/25 (rat) antigens. It is clear that monoclonal antibodies11 will eventually replace antilymphocyte globulin for immunosuppression in organ grafting12,13, but although there has been some clinical success14–16, most monoclonal reagents cause only transient reductions in their target cells in vivo17–20. This uncertainty in the potency of monoclonal antibodies has led some workers to consider them as targeting agents for such highly cytotoxic drugs as ricin A (ref. 21). We show here that unmodified monoclonal antibodies can be extremely effective at depleting cells in vivo and can be used for the selective manipulation of different aspects of the immune response.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cantor, H. & Boyse, E. A. J. exp. Med. 141, 1376 (1975).
Cantor, H. & Boyse, E. A. Immun. Rev. 33, 105 (1977).
Ledbetter, J. A., Rouse, R. V., Spedding Micklem, H. & Herzenberg, L. A. J. exp. Med. 152, 280–295 (1980).
Huber, B. H., Cantor, H., Shan, F. W. & Boyse, E. A. J. exp. Med. 144, 1128 (1976).
Reinherz, E. L. & Schlossman, S. F. Cell 19, 821–827 (1980).
Bernard, A., Boumsell, L. & Hill, C. in Leucotyte Typing: Human Leucocyte Differentiation Antigens Detected by Monoclonal Antibodies—Specification—Classification—Nomenclature (eds Bernard, A., Boumsell, L., Dausset, J., Milstein, C. & Schlossman, S. F.) 9–60 (Springer, New York, 1984).
Ledbetter, J. A. & Herzenberg, L. A. Immun. Rev. 47, 63–90 (1979).
Mason, D. W. et al. Immun. Rev. 74, 57–82 (1983).
Dialynas, D. P. et al., J. Immun. 131, 2445–2451 (1983).
Dialynas, D. P. et al. Immun. Rev. 74, 29–56 (1983).
Kohler, G. & Milstein, C. Nature 256, 495–497 (1975).
Monaco, A. P. et al. J. Immun. 96, 229–238 (1966).
Hunt, S. A. & Stinson, E. B. A. Rev. Med. 32, 213–220 (1981).
Reinherz, E. L. et al. Proc. natn. Acad. Sci. USA 79, 6047 (1982).
Takahashi, H. et al. Lancet ii, 1155–1157 (1983).
Miller, R. A. & Levy, R. Lancet ii, 226–230 (1981).
Ritz, J. & Schlossman, S. F. Blood 59, 1–11 (1982).
Fabre, J. W., Sunderland, C. A. & Williams, A. F. Transplantn Proc. 13, 509–511 (1981).
Bernstein, I. D. et al. in Monoclonal Antibodies. Hybridomas: A New Dimension in Biological Analyses (eds Kennet, R. H., McKearn, T. J. & Bechtol, K. B.) 275–291 (Plenum, New York, 1981).
Thierfelder, S. et al. Transplantation 35, 249–254 (1983).
Thorpe, P. E. et al. in Monoclonal Antibodies in Clinical Medicine (eds Fabre, J. & McMichael, A.) 167–201 (Academic, London, 1982).
Ledbetter, J. A. & Seaman, W. E. Immun. Rev. 68, 197–218 (1982).
Cobbold, S. P., Thierfelder, S. & Waldmann, H. Molec. Biol. Med. 1, 285–304 (1983).
Cobbold, S. P. thesis, Univ. Cambridge (1983).
Galfre, G., Milstein, C. & Wright, B. Nature 277, 131–133 (1979).
Taussig, M. J. The Antigens Vol. 4 (ed. Sela, M.) 333–368 (1977).
Opitz et al. Immunobiology 160, 438–453 (1982).
LeGros, G. S., Prestige, R. L. & Watson, J. D. Immunology 50, 537–546 (1983).
Thomas, D. B. & Calderon, R. A. Eur. J. Immun. 12, 16–23 (1982).
Nash, A. A. & Gell, P. G. H. Cell. Immun. 75, 348–355 (1983).
Loveland, B. E., Hogarth, P. M., Ceredig, R. H. & McKenzie, I. F. C. J. exp. Med. 153, 1044 (1982).
Roehm, N. W., Alter, B. J. & Bach, F. H. J. Immun. 126, 353–358 (1981).
LeFrancois, L. & Bevan, M. J. J. exp. Med. 159, 57–67 (1984).
Michaelides, L., Hogarth, P. M. & McKenzie, I. F. C. Eur. J. Immun. 11, 1005–1012 (1981).
Tyler, J. D. et al. J. exp. Med. 159, 234–243 (1984).
Aqel, N. M., Clark, M., Cobbold, S. P. & Waldmann, H. J. immun. Meth. 69, 207–214 (1984).
Dallman, M. J., Mason, D. W. & Webb, M. Eur. J. Immun. 12, 511–518 (1982).
Clark, M. R., Cobbold, S. P., Hale, G. & Waldmann, H. Immun. Today 4, 100–101 (1983).
Fust, G., Medgyesi, G. A., Bazin, H. & Gergely, J. Immun. Lett. 1, 249–253 (1980).
Hughes-Jones, N. C., Gorick, B. D. & Howard, J. C. Eur. J. Immun. 13, 635–641 (1980).
Hale, G., Clark, M. & Waldmann, H. Biochem. Soc. Trans. 12, 878 (1984).
Lanier, L. L. et al. Hybridoma 1, 121–131 (1982).
Nash, A. A., Gell, P. G. H. & Wildy, P. Immunology 43, 153–159 (1981).
Nash, A. A., Field, H. J. & Quartey-Papafio, R. J. gen. Virol. 48, 351–357 (1980).
Burnette, W. N. Analyt. Biochem. 112, 195–203 (1981).
Watt, S. M. et al. J. cell. Physiol. 115, 37–45 (1983).
Omary, M. B., Trowbridge, I. S. & Scheid, M. P. J. exp. Med. 151, 1311–1316 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cobbold, S., Jayasuriya, A., Nash, A. et al. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312, 548–551 (1984). https://doi.org/10.1038/312548a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/312548a0
This article is cited by
-
Roles and regulation of microglia activity in multiple sclerosis: insights from animal models
Nature Reviews Neuroscience (2023)
-
Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy
EJNMMI Research (2022)
-
Donor bone-marrow CXCR4+ Foxp3+ T-regulatory cells are essential for costimulation blockade-induced long-term survival of murine limb transplants
Scientific Reports (2020)
-
Versatile cell ablation tools and their applications to study loss of cell functions
Cellular and Molecular Life Sciences (2019)
-
PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
Nature Communications (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.